NEW YORK ( TheStreet) -- CHANGE IN RATINGSAmylin Pharmaceuticals ( AMLN) downgraded at BMO from Market Perform to Underperform. $12 price target. LAR approval could be delayed until late 2011, as the FDA will likely request more clinical data. Avery Dennison ( AVY) downgraded at BofA/Merrill to Neutral from Buy as valuation and fundamentals are less compelling. $35 price target. Boeing ( BA) upgraded at UBS from Sell to Neutral. $68 price target. Estimates also boosted, because of a higher delivery forecast. Convergys ( CVG) downgraded at Kaufman from Hold to Sell. Valuation call, as the stock is up 16% since the recent CEO change. $11 price target. Disney ( DIS) upgraded at BofA/Merrill to Buy from Neutral on expectations that 2011 earnings will beat expectations. Estimates raised through 2012. Price target boosted to $42 from $33. Dole Food ( DOLE) rated new Equal-weight at Morgan Stanley. Core fruit business has limited upside potential from current levels. FedEx ( FDX) upgraded at Morgan Keegan from Market Perform to Outperform. Company has strong earnings leverage as volumes recover. Coca-Cola ( KO) upgraded at UBS from Neutral to Buy. $62 price target. Valuation call, as the company has been showing strong volume and cash flow growth. Liberty Starz ( LSTZA) rated new Buy at UBS. $65 price target. Stock is overly discounting future programming costs and sports and attractive 10% free cash flow yield. Madison Square Garden ( MSG) rated new Neutral at UBS. Coverage of MSG was started with a Neutral rating. $22 price target. Company will spend more to upgrade its arena in 2011. Valuation also appears high. Royal Caribbean ( RCL) upgraded at Goldman from Sell to Neutral. Estimates also raised, as the new Oasis and Solstice ships are showing a significant relative premium. $27 price target. Spirit Aerosystems ( SPR) upgraded at UBS from Sell to Neutral. $22 price target. Higher deliveries should drive earnings.
Alon USA Energy ( ALJ) target, estimate cut at Barclays. ALJ price target trimmed by a dollar to $6 on weak 4Q09 results. 2010 EPS estimate lowered to -$1.85. Underweight rating. Anadarko Petroleum ( APC) target raised at FBR to $90. Company has very attractive exploration opportunities. Outperform rating. BJ's Wholesale ( BJ) numbers lowered at Goldman. BJ estimates were cut through 2011. Company is ramping up internal investments. Sell rating and new $31 price target. Costco ( COST) estimates lowered at Goldman through 2012. Gross margin is facing more difficult comparisons. Neutral rating and $61 price target. Energizer ( ENR) estimates, target increased at Goldman. ENR estimates were boosted through 2012. New Schick and Edge razors should drive organic sales growth. Neutral rating and new $68 price target. Finisar ( FNSR) price target boosted at Credit Suisse. FNSR price target raised to $13.50 from $11 after solid 3Q10 results. Neutral rating. 2010 and 2011 EPS estimates set at 52 cents and 90 cents, respectively. Hershey ( HSY) estimates, target boosted at UBS. Shares of HSY now seen reaching $42. Estimates also raised, as the new analyst believes that the company is gaining brand momentum. Neutral rating. Joy Global ( JOYG) estimate tweaked at Barclays. JOYG 2010 EPS estimate inched up to 3.10, 2011 maintained at $3.95. Maintain Overweight rating and $67 price target. Joy Global ( JOYG) estimates, target upped at Goldman. Shares of JOYG now seen reaching $64. Estimates also boosted, given higher equipment production. Neutral rating. Kroger ( KR) estimates upped at Morgan Stanley through 2011. Company is being less aggressive with pricing and gross margin should stabilize. Equal-weight rating. Las Vegas Sands ( LVS) numbers cut at Goldman through 2011. Company seeing lower profits in Las Vegas properties. Neutral rating and new $17 price target. Mariner Energy ( ME) price target raised at Credit Suisse by a dollar to $18 as it continues to build its onshore asset base. 2010 and 2011 EPS estimates changed to -$0.29 and $0.13, respectively. Maintain Outperform rating. NYSE Euronext ( NYX) numbers increased at Goldman. Shares of NYX now seen reaching $32. Estimates also boosted, as management is cutting costs and should be able to generate incremental revenue growth.
PetSmart ( PETM) price target higher at Credit Suisse. PETM price target surged to $35 from $29. PetSmart is one of our most attractive manes going forward, Credit Suisse said. 2011 and 2012 EPS estimates raised to $1.85 and $2.13, respectively. Maintain Outperform rating. PetSmart ( PETM) estimates, target raised at Goldman. Shares of PETM now seen reaching $32. Estimates also upped, to reflect an active share repurchase program. Neutral rating. Staples ( SPLS) target lowered at Citigroup. Shares of SPLS now seen reaching $26. Stock could receive a more conservative multiple, following the company's lower earnings guidance. Buy rating. Torchmark ( TMK) price target boosted at BofA/Merrill to $57 from $55 as share buybacks resume. 2011 EPS estimate bumped up to $6.75. Reiterate Buy. Texas Instruments ( TXN) price target higher at Thomas Weisel, to $32 from $30 on solid guidance. Maintain Overweight rating. URS Corp ( URS) target, estimate raised at Barclays. URS price target increased a dollar to $53 on strong 2010 guidance. 2010 EPS estimate jumped 10 cents to $3.45. Equal Weight rating. URS ( URS) estimates, target increased at UBS. Shares of URS now seen reaching $51. Estimates also raised, to match the company's new guidance. Neutral rating.